MULTIPLE SCLEROSIS
![Foto de MULTIPLE SCLEROSIS](/img/grupo.png)
![Foto de Instituto de Investigación Sanitaria Biogipuzkoa](/img/noimage_org.png)
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublications in collaboration with researchers from Instituto de Investigación Sanitaria Biogipuzkoa (89)
2024
-
Centenarian hippocampus displays high levels of astrocytic metallothioneins
Aging Cell, Vol. 23, Núm. 8
-
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?
Translational Neurodegeneration, Vol. 13, Núm. 1
-
Chronic defeat stress induces monoamine level dysregulation in the prefrontal cortex but not in the hippocampus of OF1 male mice
Behavioural Brain Research, Vol. 467
-
Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches
Journal of Extracellular Vesicles, Vol. 13, Núm. 2
2023
-
Blood RNA-Seq profiling reveals a set of circular RNAs differentially expressed in frail individuals
Immunity and Ageing, Vol. 20, Núm. 1
-
Dysautonomia and small fiber neuropathy in post-COVID condition and Chronic Fatigue Syndrome
Journal of Translational Medicine, Vol. 21, Núm. 1
-
Early biochemical analysis of COVID-19 patients helps severity prediction
PLoS ONE, Vol. 18, Núm. 5 May
-
Editorial: Innovative OMICs-technology applications to reach a diagnosis and bring new therapies to immune-mediated neurological diseases
Frontiers in Immunology
-
Immune cell population and cytokine profiling suggest age dependent differences in the response to SARS-CoV-2 infection
Frontiers in Aging, Vol. 4
-
Individualized Housing Modifies the Immune–Endocrine System in CD1 Adult Male Mice
Animals, Vol. 13, Núm. 6
-
The role of sociability in social instability stress: Behavioral, neuroendocrine and monoaminergic effects
Physiology and Behavior, Vol. 270
-
Women in the field of multiple sclerosis: How they contributed to paradigm shifts
Frontiers in Molecular Neuroscience, Vol. 16
2022
-
Brain fog of post-COVID-19 condition and Chronic Fatigue Syndrome, same medical disorder?
Journal of Translational Medicine, Vol. 20, Núm. 1
-
Disease modifying therapy switching in relapsing multiple sclerosis: A Delphi consensus of the demyelinating expert group of the Spanish society of neurology
Multiple Sclerosis and Related Disorders, Vol. 63
-
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis
Human Molecular Genetics, Vol. 31, Núm. 13, pp. 2155-2163
-
Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis
Frontiers in Immunology, Vol. 13
-
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
Journal of Neuroinflammation, Vol. 19, Núm. 1
-
The innovative animal monitoring device for experimental autoimmune encephalomyelitis (“I AM D EAE”): A more detailed evaluation for improved results
Multiple Sclerosis and Related Disorders, Vol. 63
2021
-
Assessing the potential of molecular imaging for myelin quantification in organotypic cultures
Pharmaceutics, Vol. 13, Núm. 7
-
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiers in Immunology, Vol. 12